{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:34:49Z","timestamp":1792852489969,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":94,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The vice chancellor for research and technology, Hamadan university of medical sciences, Hamadan\/Iran","award":["14030204782"],"award-info":[{"award-number":["14030204782"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"DOI":"10.1186\/s12896-026-01201-6","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T09:45:54Z","timestamp":1783763154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and in vitro evaluation of teicoplanin PEGylated (TEC-PEGylated) niosomes for antimicrobial and anti-biofilm activity against vancomycin-intermediate Staphylococcus aureus (VISA)"],"prefix":"10.1186","volume":"26","author":[{"given":"Jaber","family":"Hemmati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Chegini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraj","family":"Sedighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raha Zare","family":"Shahraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Chiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9991-8193","authenticated-orcid":false,"given":"Mohammad Reza","family":"Arabestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"issue":"4","key":"1201_CR1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1574-695X.1997.tb01101.x","volume":"19","author":"A Orenstein","year":"1997","unstructured":"Orenstein A, Klein D, Kopolovic J, Winkler E, Malik Z, Keller N, et al. The use of porphyrins for eradication of Staphylococcus aureus in burn wound infections. FEMS Immunol Med Microbiol. 1997;19(4):307\u201314.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"1","key":"1201_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12896-024-00874-1","volume":"24","author":"J Hemmati","year":"2024","unstructured":"Hemmati J, Chiani M, Asghari B, Roshanaei G, Soleimani Asl S, Shafiei M, et al. Antibacterial and antibiofilm potentials of vancomycin-loaded niosomal drug delivery system against methicillin-resistant Staphylococcus aureus (MRSA) infections. BMC Biotechnol. 2024;24(1):47.","journal-title":"BMC Biotechnol"},{"issue":"1","key":"1201_CR3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/pathogens5010022","volume":"5","author":"KA Lacey","year":"2016","unstructured":"Lacey KA, Geoghegan JA, McLoughlin RM. The role of Staphylococcus aureus virulence factors in skin infection and their potential as vaccine antigens. Pathogens. 2016;5(1):22.","journal-title":"Pathogens"},{"issue":"1","key":"1201_CR4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcma.2017.07.012","volume":"81","author":"M Jamal","year":"2018","unstructured":"Jamal M, Ahmad W, Andleeb S, Jalil F, Imran M, Nawaz MA, et al. Bacterial biofilm and associated infections. J Chin Med Assoc. 2018;81(1):7\u201311.","journal-title":"J Chin Med Assoc"},{"key":"1201_CR5","doi-asserted-by":"crossref","first-page":"589640","DOI":"10.3389\/fmicb.2020.589640","volume":"11","author":"L Zhou","year":"2020","unstructured":"Zhou L, Zhang Y, Ge Y, Zhu X, Pan J. Regulatory Mechanisms and Promising Applications of Quorum Sensing-Inhibiting Agents in Control of Bacterial Biofilm Formation. Front Microbiol. 2020;11:589640.","journal-title":"Front Microbiol"},{"issue":"4","key":"1201_CR6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/apm.12673","volume":"125","author":"O Ciofu","year":"2017","unstructured":"Ciofu O, Rojo-Molinero E, Macia MD, Oliver A. Antibiotic treatment of biofilm infections. APMIS. 2017;125(4):304\u201319.","journal-title":"APMIS"},{"issue":"3","key":"1201_CR7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/1574891X08666131112143447","volume":"8","author":"M Sevgi","year":"2013","unstructured":"Sevgi M, Toklu A, Vecchio D, Hamblin R. Topical antimicrobials for burn infections\u2013an update. Recent Pat Antiinfect Drug Discov. 2013;8(3):161\u201397.","journal-title":"Recent Pat Antiinfect Drug Discov"},{"issue":"5","key":"1201_CR8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1742-481X.2011.00910.x","volume":"9","author":"M Baffoni","year":"2012","unstructured":"Baffoni M, Bessa LJ, Grande R, Di Giulio M, Mongelli M, Ciarelli A, et al. Laser irradiation effect on Staphylococcus aureus and Pseudomonas aeruginosa biofilms isolated from venous leg ulcer. Int Wound J. 2012;9(5):517\u201324.","journal-title":"Int Wound J"},{"issue":"1","key":"1201_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12941-024-00760-w","volume":"23","author":"M Nazari","year":"2024","unstructured":"Nazari M, Taheri M, Nouri F, Bahmanzadeh M, Alikhani MY. The antimicrobial and antibiofilm effects of gentamicin, imipenem, and fucoidan combinations against dual-species biofilms of Staphylococcus aureus and Acinetobacter baumannii isolated from diabetic foot ulcers. Ann Clin Microbiol Antimicrob. 2024;23(1):101.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"1201_CR10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.msec.2017.11.028","volume":"85","author":"K Prusty","year":"2018","unstructured":"Prusty K, Swain SK. Nano silver decorated polyacrylamide\/dextran nanohydrogels hybrid composites for drug delivery applications. Mater Sci Eng C Mater Biol Appl. 2018;85:130\u201341.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"1","key":"1201_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccell.2003.09.008","volume":"16","author":"S Honari","year":"2004","unstructured":"Honari S. Topical therapies and antimicrobials in the management of burn wounds. Crit Care Nurs Clin North Am. 2004;16(1):1\u201311.","journal-title":"Crit Care Nurs Clin North Am"},{"issue":"1","key":"1201_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41598-020-79834-6","volume":"11","author":"AA Abdellatif","year":"2021","unstructured":"Abdellatif AA, Alturki HN, Tawfeek HM. Different cellulosic polymers for synthesizing silver nanoparticles with antioxidant and antibacterial activities. Sci Rep. 2021;11(1):84.","journal-title":"Sci Rep"},{"issue":"1","key":"1201_CR13","first-page":"5298565","volume":"2023","author":"J Hemmati","year":"2023","unstructured":"Hemmati J, Chegini Z, Arabestani MR. Niosomal-based drug delivery platforms: a promising therapeutic approach to fight staphylococcus aureus drug resistance. J Nanomaterials. 2023;2023(1):5298565.","journal-title":"J Nanomaterials"},{"issue":"4","key":"1201_CR14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/gels11040230","volume":"11","author":"J Hemmati","year":"2025","unstructured":"Hemmati J, Sedighi I, Azizi M, Chegini Z, Zare Shahraki R, Chiani M, et al. Formulation and characterization of teicoplanin niosomal gel for healing chronic wounds infected with methicillin-resistant Staphylococcus aureus (MRSA). Gels. 2025;11(4):230.","journal-title":"Gels"},{"issue":"1","key":"1201_CR15","doi-asserted-by":"publisher","first-page":"13362","DOI":"10.1038\/s41598-024-64416-7","volume":"14","author":"J Hemmati","year":"2024","unstructured":"Hemmati J, Chiani M, Chegini Z, Seifalian A, Arabestani MR. Surface modified niosomal quercetin with cationic lipid: an appropriate drug delivery system against Pseudomonas aeruginosa Infections. Sci Rep. 2024;14(1):13362.","journal-title":"Sci Rep"},{"issue":"3","key":"1201_CR16","first-page":"189","volume":"84","author":"A Salimi","year":"2014","unstructured":"Salimi A, Talaie H, Hemami MR, Mahdavinejad A, Barari BB, Razi P, et al. Teicoplanin as an anti-methicillin resistant Staphylococcus aureus agent in infections of severely poisoned intensive care unit patients\/Tehran-Iran. Acta Biomed. 2014;84(3):189\u201395.","journal-title":"Acta Biomed"},{"key":"1201_CR17","doi-asserted-by":"publisher","unstructured":"Tsai C-Y, Lee C-H, Chen I-L. Daptomycin versus teicoplanin for bloodstream infection due to methicillin-resistant Staphylococcus aureus with a high teicoplanin minimal inhibitory concentration\u2009\u2265\u20091.5\u00a0mg\/L: a propensity score-based analysis. Infect Drug Resist. 2018 Oct 26;11:2011\u201320. https:\/\/doi.org\/10.2147\/IDR.S184411.","DOI":"10.2147\/IDR.S184411"},{"issue":"12","key":"1201_CR18","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1093\/jac\/dkx289","volume":"72","author":"V Ramos-Mart\u00edn","year":"2017","unstructured":"Ramos-Mart\u00edn V, Johnson A, McEntee L, Farrington N, Padmore K, Cojutti P, et al. Pharmacodynamics of teicoplanin against MRSA. J Antimicrob Chemother. 2017;72(12):3382\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"1201_CR19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/pharmaceutics12030264","volume":"12","author":"MK Lee","year":"2020","unstructured":"Lee MK. Liposomes for Enhanced Bioavailability of Water-Insoluble Drugs: In Vivo Evidence and Recent Approaches. Pharmaceutics. 2020;12(3):264.","journal-title":"Pharmaceutics"},{"issue":"1","key":"1201_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1208\/s12249-024-02988-3","volume":"26","author":"L Bhute","year":"2024","unstructured":"Bhute L, Dighe S, Katari O, Yadav V, Jain S. Bifunctional Oxaliplatin (IV) Prodrug Based pH-Sensitive PEGylated Liposomes for Synergistic Anticancer Action Against Triple Negative Breast cancer. AAPS PharmSciTech. 2024;26(1):2.","journal-title":"AAPS PharmSciTech"},{"key":"1201_CR21","doi-asserted-by":"publisher","unstructured":"Younis MA, Alsogaihi MA, Abdellatif AA, Saleem I. Nanoformulations in the treatment of lung cancer: current status and clinical potential. Drug Dev Ind Pharm. 2025 Sep;51(9):1088\u2013104. https:\/\/doi.org\/10.1080\/03639045.2024.2437562.","DOI":"10.1080\/03639045.2024.2437562"},{"key":"1201_CR22","doi-asserted-by":"crossref","first-page":"113466","DOI":"10.1016\/j.colsurfb.2023.113466","volume":"229","author":"AA Abdellatif","year":"2023","unstructured":"Abdellatif AA, Scagnetti G, Younis MA, Bouazzaoui A, Tawfeek HM, Aldosari BN, et al. Non-coding RNA-directed therapeutics in lung cancer: delivery technologies and clinical applications. Colloids Surf B. 2023;229:113466.","journal-title":"Colloids Surf B"},{"issue":"1","key":"1201_CR23","doi-asserted-by":"crossref","first-page":"2742569","DOI":"10.1155\/cjid\/2742569","volume":"2025","author":"J Hemmati","year":"2025","unstructured":"Hemmati J, Chiani M, Asghari B, Roshanaei G, Asl SS, Shafiei M, et al. The Inhibitory Effect of Niosome Containing Myrtenol as an Innovative Approach to Combat Methicillin-Resistant Staphylococcus aureus (MRSA). Can J Infect Dis Med Microbiol. 2025;2025(1):2742569.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"2","key":"1201_CR24","first-page":"393","volume":"13","author":"Z Hadian","year":"2014","unstructured":"Hadian Z, Sahari MA, Moghimi HR, Barzegar M. Formulation, characterization and optimization of liposomes containing eicosapentaenoic and docosahexaenoic acids; a methodology approach. Iran J Pharm Res. 2014;13(2):393.","journal-title":"Iran J Pharm Res"},{"key":"1201_CR25","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.foodchem.2019.05.015","volume":"293","author":"M Rezvani","year":"2019","unstructured":"Rezvani M, Hesari J, Peighambardoust SH, Manconi M, Hamishehkar H, Escribano-Ferrer E. Potential application of nanovesicles (niosomes and liposomes) for fortification of functional beverages with Isoleucine-Proline-Proline: A comparative study with central composite design approach. Food Chem. 2019;293:368\u201377.","journal-title":"Food Chem"},{"issue":"12","key":"1201_CR26","doi-asserted-by":"publisher","first-page":"4768","DOI":"10.1016\/j.apt.2020.11.008","volume":"31","author":"F Heidari","year":"2020","unstructured":"Heidari F, Akbarzadeh I, Nourouzian D, Mirzaie A, Bakhshandeh H. Optimization and characterization of tannic acid loaded niosomes for enhanced antibacterial and anti-biofilm activities. Adv Powder Technol. 2020;31(12):4768\u201381. https:\/\/doi.org\/10.1016\/j.apt.2020.11.008.","journal-title":"Adv Powder Technol"},{"key":"1201_CR27","doi-asserted-by":"crossref","first-page":"104231","DOI":"10.1016\/j.bioorg.2020.104231","volume":"103","author":"A Mirzaie","year":"2020","unstructured":"Mirzaie A, Peirovi N, Akbarzadeh I, Moghtaderi M, Heidari F, Yeganeh FE, et al. Preparation and optimization of ciprofloxacin encapsulated niosomes: A new approach for enhanced antibacterial activity, biofilm inhibition and reduced antibiotic resistance in ciprofloxacin-resistant methicillin-resistance Staphylococcus aureus. Bioorg Chem. 2020;103:104231.","journal-title":"Bioorg Chem"},{"issue":"6","key":"1201_CR28","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.3390\/molecules18066852","volume":"18","author":"A Blainski","year":"2013","unstructured":"Blainski A, Lopes GC, De Mello JCP. Application and analysis of the folin ciocalteu method for the determination of the total phenolic content from Limonium brasiliense L. Molecules. 2013;18(6):6852\u201365.","journal-title":"Molecules"},{"key":"1201_CR29","unstructured":"Clinical and Laboratory Standards Institutes (CLSI). Clinical and laboratory standards for antimicrobial susceptibility testing. 2019. p. 1\u2013319."},{"key":"1201_CR30","first-page":"M7","volume":"26","author":"MA W","year":"2006","unstructured":"MA W. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. Clsi (Nccls). 2006;26:M7\u2013A.","journal-title":"Clsi (Nccls)"},{"issue":"2","key":"1201_CR31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000542826","volume":"70","author":"M Nazari","year":"2025","unstructured":"Nazari M, Taheri M, Nouri F, Bahmanzadeh M, Alikhani MY. Time-kill curve analysis of fucoidan combination with conventional antibiotics against biofilms formation of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii clinical isolates. Chemotherapy. 2025;70(2):53\u201364.","journal-title":"Chemotherapy"},{"issue":"10","key":"1201_CR32","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1128\/AAC.03035-14","volume":"58","author":"G Pankey","year":"2014","unstructured":"Pankey G, Ashcraft D, Kahn H, Ismail A. Time-kill assay and Etest evaluation for synergy with polymyxin B and fluconazole against Candida glabrata. Antimicrob Agents Chemother. 2014;58(10):5795\u2013800.","journal-title":"Antimicrob Agents Chemother"},{"key":"1201_CR33","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10096-018-3189-7","volume":"37","author":"AM Bardbari","year":"2018","unstructured":"Bardbari AM, Arabestani MR, Karami M, Keramat F, Aghazadeh H, Alikhani MY, et al. Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis. 2018;37:443\u201354.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1201_CR34","unstructured":"Eales M. The visualisation of interactions between Acinetobacter baumannii and the antimicrobial peptides: colistin sulphate, bicarinalin and BP100. University of Lincoln; 2015."},{"issue":"3","key":"1201_CR35","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1128\/AAC.02473-13","volume":"58","author":"R Gopal","year":"2014","unstructured":"Gopal R, Kim YG, Lee JH, Lee SK, Chae JD, Son BK, et al. Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains. Antimicrob Agents Chemother. 2014;58(3):1622\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1201_CR36","doi-asserted-by":"publisher","first-page":"21938","DOI":"10.1038\/s41598-022-26400-x","volume":"12","author":"A Haddadian","year":"2022","unstructured":"Haddadian A, Robattorki FF, Dibah H, Soheili A, Ghanbarzadeh E, Sartipnia N, et al. Niosomes-loaded selenium nanoparticles as a new approach for enhanced antibacterial, anti-biofilm, and anticancer activities. Sci Rep. 2022;12(1):21938.","journal-title":"Sci Rep"},{"issue":"1","key":"1201_CR37","doi-asserted-by":"publisher","first-page":"16692","DOI":"10.1038\/s41598-024-67509-5","volume":"14","author":"H Rezaei","year":"2024","unstructured":"Rezaei H, Iranbakhsh A, Sepahi AA, Mirzaie A, Larijani K. Formulation, preparation of niosome loaded zinc oxide nanoparticles and biological activities. Sci Rep. 2024;14(1):16692.","journal-title":"Sci Rep"},{"issue":"3","key":"1201_CR38","doi-asserted-by":"crossref","first-page":"e0264825","DOI":"10.1371\/journal.pone.0264825","volume":"17","author":"NS Heredia","year":"2022","unstructured":"Heredia NS, Vizuete K, Flores-Calero M, Pazmi\u00f1o VK, Pilaquinga F, Kumar B, et al. Comparative statistical analysis of the release kinetics models for nanoprecipitated drug delivery systems based on poly (lactic-co-glycolic acid). PLoS ONE. 2022;17(3):e0264825.","journal-title":"PLoS ONE"},{"issue":"1","key":"1201_CR39","doi-asserted-by":"publisher","first-page":"4736","DOI":"10.1038\/s41598-020-61605-y","volume":"10","author":"AA Abdellatif","year":"2020","unstructured":"Abdellatif AA, Ibrahim MA, Amin MA, Maswadeh H, Alwehaibi MN, Al-Harbi SN, et al. Cetuximab conjugated with octreotide and entrapped calcium alginate-beads for targeting somatostatin receptors. Sci Rep. 2020;10(1):4736.","journal-title":"Sci Rep"},{"key":"1201_CR40","doi-asserted-by":"publisher","unstructured":"Abdellatif AA, Rasheed Z, Alhowail AH, Alqasoumi A, Alsharidah M, Khan RA et al. Silver citrate nanoparticles inhibit PMA-induced TNF\u03b1 expression via deactivation of NF-\u03baB activity in human cancer cell-lines, MCF-7. Int J Nanomed. 2020: Oct 30;15:8479\u201393. https:\/\/doi.org\/10.2147\/IJN.S274098.","DOI":"10.2147\/IJN.S274098"},{"key":"1201_CR41","doi-asserted-by":"crossref","first-page":"100837","DOI":"10.1016\/j.mtbio.2023.100837","volume":"23","author":"A Moammeri","year":"2023","unstructured":"Moammeri A, Chegeni MM, Sahrayi H, Ghafelehbashi R, Memarzadeh F, Mansouri A, et al. Current advances in niosomes applications for drug delivery and cancer treatment. Mater Today Bio. 2023;23:100837.","journal-title":"Mater Today Bio"},{"issue":"1","key":"1201_CR42","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijantimicag.2008.02.009","volume":"32","author":"AS Kwon","year":"2008","unstructured":"Kwon AS, Park GC, Ryu SY, Lim DH, Lim DY, Choi CH, et al. Higher biofilm formation in multidrug-resistant clinical isolates of Staphylococcus aureus. Int J Antimicrob Agents. 2008;32(1):68\u201372.","journal-title":"Int J Antimicrob Agents"},{"key":"1201_CR43","doi-asserted-by":"publisher","unstructured":"Neopane P, Nepal HP, Shrestha R, Uehara O, Abiko Y. In vitro biofilm formation by Staphylococcus aureus isolated from wounds of hospital-admitted patients and their association with antimicrobial resistance. Int J Gen Med. 2018: Jan 18;11:25\u201332. https:\/\/doi.org\/10.2147\/IJGM.S153268.","DOI":"10.2147\/IJGM.S153268"},{"key":"1201_CR44","doi-asserted-by":"publisher","unstructured":"Shirin NJ, Gharaghie TP, Beiranvand S, Riahi A, Fattahi N. Encapsulation and characterization of meropenem in niosome nanoparticles and inhibitory effects of antibiofilm and antibacterial on methicillin and vancomycin resistant strains of Staphylococcus aureus. https:\/\/doi.org\/10.21203\/rs.3.rs-191656\/v1.","DOI":"10.21203\/rs.3.rs-191656\/v1"},{"issue":"10","key":"1201_CR45","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1080\/03639045.2022.2027958","volume":"47","author":"P Shadvar","year":"2021","unstructured":"Shadvar P, Mirzaie A, Yazdani S. Fabrication and optimization of amoxicillin-loaded niosomes: an appropriate strategy to increase antimicrobial and anti-biofilm effects against multidrug-resistant Staphylococcus aureus strains. Drug Dev Ind Pharm. 2021;47(10):1568\u201377.","journal-title":"Drug Dev Ind Pharm"},{"key":"1201_CR46","doi-asserted-by":"publisher","unstructured":"El-Readi MZ, Abdulkarim MA, Abdellatif AA, Elzubeir ME, Refaat B, Althubiti M, et al. Doxorubicin-sanguinarine nanoparticles: formulation and evaluation of breast cancer cell apoptosis and cell cycle. Drug Dev Ind Pharm. 2024:51(9):987\u20131001. https:\/\/doi.org\/10.1080\/03639045.2024.2302557.","DOI":"10.1080\/03639045.2024.2302557"},{"issue":"11","key":"1201_CR47","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.3109\/03639045.2016.1173052","volume":"42","author":"AA Abdellatif","year":"2016","unstructured":"Abdellatif AA, Zayed G, El-Bakry A, Zaky A, Saleem IY, Tawfeek HM. Novel gold nanoparticles coated with somatostatin as a potential delivery system for targeting somatostatin receptors. Drug Dev Ind Pharm. 2016;42(11):1782\u201391.","journal-title":"Drug Dev Ind Pharm"},{"key":"1201_CR48","doi-asserted-by":"crossref","unstructured":"Umbarkar MG. Niosome as a novel pharmaceutical drug delivery: a brief review highlighting formulation, types, composition and application. Indian J Pharm Educ Res. 2021;55.","DOI":"10.5530\/ijper.55.1s.34"},{"issue":"7","key":"1201_CR49","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1248\/bpb.34.945","volume":"34","author":"R Rajera","year":"2011","unstructured":"Rajera R, Nagpal K, Singh SK, Mishra DN. Niosomes: a controlled and novel drug delivery system. Biol Pharm Bull. 2011;34(7):945\u201353.","journal-title":"Biol Pharm Bull"},{"issue":"7","key":"1201_CR50","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1089\/wound.2014.0538","volume":"4","author":"EM Jones","year":"2015","unstructured":"Jones EM, Cochrane CA, Percival SL. The effect of pH on the extracellular matrix and biofilms. Adv wound care. 2015;4(7):431\u20139.","journal-title":"Adv wound care"},{"issue":"5","key":"1201_CR51","doi-asserted-by":"crossref","first-page":"2302868","DOI":"10.1002\/adhm.202302868","volume":"13","author":"H Su","year":"2024","unstructured":"Su H, Chen Y, Jing X, Zhao X, Sun H, Liu Z, et al. Antimicrobial, antioxidant, and anti-inflammatory nanoplatform for effective management of infected wounds. Adv Healthc Mater. 2024;13(5):2302868.","journal-title":"Adv Healthc Mater"},{"key":"1201_CR52","first-page":"189","volume-title":"Water diffusion and sorption in amorphous macromolecular systems and foods","author":"NA Peppas","year":"1994","unstructured":"Peppas NA, Brannon-Peppas L. Water diffusion and sorption in amorphous macromolecular systems and foods. Water in Foods: Elsevier; 1994. pp. 189\u2013210."},{"issue":"3","key":"1201_CR53","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2478\/acph-2025-0026","volume":"75","author":"S Alhabardi","year":"2025","unstructured":"Alhabardi S, Aldosari B, Al-Hamoud G, Alali SM, Al Khbiah R, Albulayhi L, et al. Niosome-based delivery systems for olanzapine: Formulation, characterisation, and kinetic evaluation. Acta Pharm. 2025;75(3):531\u201345.","journal-title":"Acta Pharm"},{"key":"1201_CR54","doi-asserted-by":"publisher","unstructured":"AbuElfadl A, Boughdady M, Meshali M. New Peceol\u2122\/Span\u2122 60 niosomes coated with chitosan for candesartan cilexetil: perspective increase in absolute bioavailability in rats. Int J Nanomed. 2021:16:16:5581-5601. https:\/\/doi.org\/10.2147\/IJN.S324171.","DOI":"10.2147\/IJN.S324171"},{"issue":"4","key":"1201_CR55","doi-asserted-by":"crossref","first-page":"2200134","DOI":"10.1002\/anbr.202200134","volume":"3","author":"BK Pothineni","year":"2023","unstructured":"Pothineni BK, Keller A. Nanoparticle-Based Formulations of Glycopeptide Antibiotics: A Means for Overcoming Vancomycin Resistance in Bacterial Pathogens? Adv NanoBiomed Res. 2023;3(4):2200134.","journal-title":"Adv NanoBiomed Res"},{"key":"1201_CR56","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.3389\/fmicb.2018.02270","volume":"9","author":"I Armenia","year":"2018","unstructured":"Armenia I, Marcone GL, Berini F, Orlandi VT, Pirrone C, Martegani E, et al. Magnetic nanoconjugated teicoplanin: a novel tool for bacterial infection site targeting. Front Microbiol. 2018;9:2270.","journal-title":"Front Microbiol"},{"issue":"40","key":"1201_CR57","doi-asserted-by":"crossref","first-page":"8492","DOI":"10.1039\/C5CC01869B","volume":"51","author":"M Kavruk","year":"2015","unstructured":"Kavruk M, Celikbicak O, Ozalp V, Borsa BA, Hernandez FJ, Bayramoglu G, et al. Antibiotic loaded nanocapsules functionalized with aptamer gates for targeted destruction of pathogens. Chem Commun. 2015;51(40):8492\u20135.","journal-title":"Chem Commun"},{"key":"1201_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11274-020-02845-y","volume":"36","author":"S Ucak","year":"2020","unstructured":"Ucak S, Sudagidan M, Borsa BA, Mansuroglu B, Ozalp VC. Inhibitory effects of aptamer targeted teicoplanin encapsulated PLGA nanoparticles for Staphylococcus aureus strains. World J Microbiol Biotechnol. 2020;36:1\u20139.","journal-title":"World J Microbiol Biotechnol"},{"issue":"9","key":"1201_CR59","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1128\/AAC.44.9.2458-2464.2000","volume":"44","author":"PM Furneri","year":"2000","unstructured":"Furneri PM, Fresta M, Puglisi G, Tempera G. Ofloxacin-loaded liposomes: in vitro activity and drug accumulation in bacteria. Antimicrob Agents Chemother. 2000;44(9):2458\u201364.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"1201_CR60","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/1061186X.2022.2032094","volume":"30","author":"M Mehrarya","year":"2022","unstructured":"Mehrarya M, Gharehchelou B, Haghighi Poodeh S, Jamshidifar E, Karimifard S, Farasati Far B, et al. Niosomal formulation for antibacterial applications. J Drug Target. 2022;30(5):476\u201393.","journal-title":"J Drug Target"},{"key":"1201_CR61","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1590\/S1517-83822012000300020","volume":"43","author":"IMS Torres","year":"2012","unstructured":"Torres IMS, Bento EB, Almeida LC, LZCMd S\u00e1, Lima EM. Preparation, characterization and in vitro antimicrobial activity of liposomal ceftazidime and cefepime against Pseudomonas aeruginosa strains. Braz J Microbiol. 2012;43:984\u201392.","journal-title":"Braz J Microbiol"},{"issue":"2","key":"1201_CR62","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1517\/17425247.2014.942639","volume":"12","author":"AA Abdelaziz","year":"2015","unstructured":"Abdelaziz AA, Elbanna TE, Sonbol FI, Gamaleldin NM, El Maghraby GM. Optimization of niosomes for enhanced antibacterial activity and reduced bacterial resistance: in vitro and in vivo evaluation. Expert Opin Drug Deliv. 2015;12(2):163\u201380. https:\/\/doi.org\/10.1517\/17425247.2014.942639.","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"1201_CR63","doi-asserted-by":"crossref","first-page":"015008","DOI":"10.1088\/2632-959X\/ad1d02","volume":"5","author":"N Osman","year":"2024","unstructured":"Osman N, Omolo CA, Gafar MA, Devnarain N, Rambharose S, Ibrahim UH, et al. Niosomes modified with a novel pH-responsive coating (mPEG-OA) enhance the antibacterial and anti-biofilm activity of vancomycin against methicillin-resistant Staphylococcus aureus. Nano Express. 2024;5(1):015008.","journal-title":"Nano Express"},{"issue":"8","key":"1201_CR64","first-page":"1330","volume":"2","author":"VP Pandey","year":"2009","unstructured":"Pandey VP, Deivasigamani K. Preparation and characterization of ofloxacin non-ionic surfactant vesicles for ophthalmic use. J Pharm Res. 2009;2(8):1330\u20134.","journal-title":"J Pharm Res"},{"issue":"31","key":"1201_CR65","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.2174\/0929867325666180313110917","volume":"25","author":"AC Raminelli","year":"2018","unstructured":"Raminelli AC, Romero V, Semreen MH, Leonardi GR. Nanotechnological advances for cutaneous release of tretinoin: an approach to minimize side effects and improve therapeutic efficacy. Curr Med Chem. 2018;25(31):3703\u201318.","journal-title":"Curr Med Chem"},{"key":"1201_CR66","doi-asserted-by":"publisher","unstructured":"Kashef MT, Saleh NM, Assar NH, Ramadan MA. The antimicrobial activity of ciprofloxacin-loaded niosomes against ciprofloxacin-resistant and biofilm-forming Staphylococcus aureus. Infect Drug Resist. 2020: Jan 8;13:1619\u201329. https:\/\/doi.org\/10.2147\/IDR.S249628.","DOI":"10.2147\/IDR.S249628"},{"issue":"8","key":"1201_CR67","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/jphp.13106","volume":"71","author":"A Allam","year":"2019","unstructured":"Allam A, El-Mokhtar MA, Elsabahy M. Vancomycin-loaded niosomes integrated within pH-sensitive in-situ forming gel for treatment of ocular infections while minimizing drug irritation. J Pharm Pharmacol. 2019;71(8):1209\u201321.","journal-title":"J Pharm Pharmacol"},{"issue":"30","key":"1201_CR68","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1016\/j.biomaterials.2008.07.014","volume":"29","author":"MR Nejadnik","year":"2008","unstructured":"Nejadnik MR, van der Mei HC, Norde W, Busscher HJ. Bacterial adhesion and growth on a polymer brush-coating. Biomaterials. 2008;29(30):4117\u201321.","journal-title":"Biomaterials"},{"issue":"6","key":"1201_CR69","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/adma.201001215","volume":"23","author":"I Banerjee","year":"2011","unstructured":"Banerjee I, Pangule RC, Kane RS. Antifouling coatings: recent developments in the design of surfaces that prevent fouling by proteins, bacteria, and marine organisms. Adv Mater. 2011;23(6):690\u2013718.","journal-title":"Adv Mater"},{"issue":"7","key":"1201_CR70","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.3390\/microorganisms10071297","volume":"10","author":"OA Rugaie","year":"2022","unstructured":"Rugaie OA, Abdellatif AA, El-Mokhtar MA, Sabet MA, Abdelfattah A, Alsharidah M, et al. Retardation of bacterial biofilm formation by coating urinary catheters with metal nanoparticle-stabilized polymers. Microorganisms. 2022;10(7):1297.","journal-title":"Microorganisms"},{"issue":"1","key":"1201_CR71","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1021\/acsami.9b17722","volume":"12","author":"X Huang","year":"2019","unstructured":"Huang X, Wang P, Li T, Tian X, Guo W, Xu B, et al. Self-assemblies based on traditional medicine berberine and cinnamic acid for adhesion-induced inhibition multidrug-resistant Staphylococcus aureus. ACS Appl Mater Interfaces. 2019;12(1):227\u201337.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"11","key":"1201_CR72","first-page":"12331","volume":"9","author":"AK Chaubey","year":"2024","unstructured":"Chaubey AK, Pratap T, Preetiva B, Patel M, Singsit JS, Pittman CU Jr, et al. Definitive review of nanobiochar. ACS omega. 2024;9(11):12331\u201379.","journal-title":"ACS omega"},{"key":"1201_CR73","doi-asserted-by":"crossref","unstructured":"Obeid MA, Tate RJ, Mullen AB, Ferro VA. Lipid-based nanoparticles for cancer treatment. In: Lipid nanocarriers for drug targeting. Elsevier; 2018. p. 313\u201359.","DOI":"10.1016\/B978-0-12-813687-4.00008-6"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12896-026-01201-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-026-01201-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-026-01201-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:44:03Z","timestamp":1791927843000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12896-026-01201-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1201"],"URL":"https:\/\/doi.org\/10.1186\/s12896-026-01201-6","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Hamadan University of Medical Sciences, Institutional Review Board (IR.UMSHA.REC.1403. 105). The experiments in our study were conducted in accordance to the relevant guidelines and regulations or in accordance to the Declaration of Helsinki. Informed consent was obtained from all patients and the parents or legal guardians of children participating in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"119"}}